StockData
Rigel Pharmaceuticals Inc logo

Rigel Pharmaceuticals Inc (RIGL) stock

RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$44.46−1.23 (-2.69%)

Close on Nov 13, 2026Market cap $830.51MP/E 2.9Yield –

Rigel Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Rigel Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2026 was 106.6%. For fiscal 2025 it was 124.7%, against 9.8% the year before. The highest annual figure on record is 124.7% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025124.7%+115.0
FY2024Dec 31, 20249.8%+31.2
FY2023Dec 31, 2023-21.5%+27.2
FY2022Dec 31, 2022-48.7%−36.7
FY2021Dec 31, 2021-12.0%+15.4
FY2020Dec 31, 2020-27.4%+85.4
FY2019Dec 31, 2019-112.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202616.3%−23.9
Q2 FY2026Jun 30, 202622.0%−36.7
Q1 FY2026Mar 31, 202614.7%−6.7
Q4 FY2025Dec 31, 2025384.0%+359.1
Q3 FY2025Sep 30, 202540.2%+17.7
Q2 FY2025Jun 30, 202558.6%+61.4
Q1 FY2025Mar 31, 202521.5%+49.4
Q4 FY2024Dec 31, 202424.9%+22.8
Q3 FY2024Sep 30, 202422.5%+42.7
Q2 FY2024Jun 30, 2024-2.8%+21.8
Q1 FY2024Mar 31, 2024-27.9%+24.0
Q4 FY2023Dec 31, 20232.1%−0.7
Q3 FY2023Sep 30, 2023-20.2%+64.7
Q2 FY2023Jun 30, 2023-24.5%+20.7
Q1 FY2023Mar 31, 2023-51.9%+112.1
Q4 FY2022Dec 31, 20222.7%+113.7
Q3 FY2022Sep 30, 2022-84.9%+12.3
Q2 FY2022Jun 30, 2022-45.2%+7.4
Q1 FY2022Mar 31, 2022-164.0%−212.8
Q4 FY2021Dec 31, 2021-110.9%−6.7
Q3 FY2021Sep 30, 2021-97.3%−20.2
Q2 FY2021Jun 30, 2021-52.6%–
Q1 FY2021Mar 31, 202148.8%–
Q4 FY2020Dec 31, 2020-104.3%–
Q3 FY2020Sep 30, 2020-77.1%–

More Rigel Pharmaceuticals figures

See a number that looks wrong?